ULTRA V is a global leader in aesthetic medicine, active in over 44 countries, with its core innovation, ULTRACOL — the world’s first PDO microsphere-based biostimulator approved by CE and KFDA. ULTRACOL stimulates natural collagen production through a controlled foreign body response, improving wrinkles, skin texture, and volume. Compared to HA and PDLLA fillers, ULTRACOL shows superior biocompatibility, biodegradability, and safety, with minimal inflammation and excellent results in long-term clinical studies Through this breakthrough, ULTRA V continues to lead in non-invasive, regenerative aesthetic solutions.